Calithera Biosciences, Inc. | PRE 14A | 0001193125-22-100502

SEC Filing Details

Document Details

Form

Filing Date

Apr 8, 2022

Document Date

Jun 1, 2022

Form Description

A preliminary proxy statement providing notification matters to be brought to a vote

Filing Group

Proxy Filings

Company

Calithera Biosciences, Inc.

Issuer

Calithera Biosciences, Inc.

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

Investor & Media Contact

Stephanie Wong
Chief Financial Officer

1.650.870.1063
ir@Calithera.com

Investor Tools